# GO_biological_process_0145: before and after transfer clarification

[All 1,328 cases](../README.md) · [Method](../METHOD.md) · [Summary](../SUMMARY.md) · [Exact reviewer user message](../inputs/GO_biological_process_0145.txt)

**Task:** `GO_biological_process`  
**Author key, unchanged:** **A** — defense response to bacterium

| Round | Reviewer | Key support | Transfer / lookup | Output usability (canonical status) |
|---|---|---|---|---|
| before | GPT-6 Luna | supported | lookup-dependent | usable output (valid_review) |
| before | Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported | usable output (valid_review) |
| after | GPT-6 Luna | supported | reasoning-supported | usable output (valid_review) |
| after | Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported | usable output (valid_review) |

**Usable output means format-valid review, not reasoning-supported or biologically correct.** A usable output can classify the question as reasoning-supported, lookup-dependent or uncertain. An output error is a problem with the saved model response; it does not count a defective benchmark question or wrong key. Each saved review is retained in full below. Labels from output errors are displayed as saved and excluded from label statistics. The author key and reviewer evidence were visible to reviewers; this is a review of answerability and key support, not a benchmark-solving score.

## Complete original question

```text
[Protein Sequence]
MQFKKQLMVIFLAYFLVVNESEAFFGHLFKLATKIIPSLFRRKNQRSRSIMKRDLENLFDPYQRNLELDRLLKQLPNY

[Multiple Choices]
A. defense response to bacterium
B. modulation of process of another organism
C. synaptonemal complex disassembly
D. endocytosis
```

<details>
<summary>Complete original system instructions</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Gene Ontology (GO) Biological Process Prediction, which is to predict the primary biological process a given protein participates in, as defined by the Gene Ontology (GO) 'Biological Process' branch. A biological process is a series of molecular events that accomplishes a larger biological program, such as cell division or signal transduction. Based on the provided protein sequence, you must select the option that best describes the overall biological objective to which the protein contributes.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## Four saved visible reviews

## Before: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The exact sequence matches the archived UniProt record for an antimicrobial peptide. That record reports experimental evidence of activity against multiple bacteria, including membrane disruption, supporting a role in defense response to bacterium. The GO annotation itself is keyword-inferred, while the functional activity is linked to experimental evidence.

Citations as saved: [H3](#evidence-h3), [H4](#evidence-h4), [C5](#evidence-c5).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence has a hydrophobic N-terminal region and a basic, likely secreted peptide region, which may suggest an antimicrobial peptide, but those features do not establish its specific biological process.


**Missing item-specific fact**

> The peptide’s experimentally observed antibacterial activity and its identity as marcin-18 are not supplied in the question.


**Reason**

> Selecting the specific process requires knowing this peptide’s functional activity. General sequence features alone do not reliably distinguish defense against bacteria from the broader effect on another organism represented by option B.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[
  "A",
  "B"
]
```

> A is the specific process supported by the record. Because the peptide disrupts bacterial membranes, B’s broader description of changing a process in another organism could also apply; the question does not clarify whether it seeks the most specific applicable GO term.


### Important caveats

- The source record is sequence-matched, but the author's exact database snapshot is unknown.
- The experimental functional evidence supports antibacterial activity; the cited GO annotation uses an inferred-evidence code.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence has a hydrophobic N-terminal region and a basic, likely secreted peptide region, which may suggest an antimicrobial peptide, but those features do not establish its specific biological process.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The peptide’s experimentally observed antibacterial activity and its identity as marcin-18 are not supplied in the question.",
    "reason": "Selecting the specific process requires knowing this peptide’s functional activity. General sequence features alone do not reliably distinguish defense against bacteria from the broader effect on another organism represented by option B."
  },
  "case_id": "GO_biological_process_0145",
  "expected_answer_check": {
    "evidence_ids": [
      "H3",
      "H4",
      "C5"
    ],
    "judgment": "supported",
    "reason": "The exact sequence matches the archived UniProt record for an antimicrobial peptide. That record reports experimental evidence of activity against multiple bacteria, including membrane disruption, supporting a role in defense response to bacterium. The GO annotation itself is keyword-inferred, while the functional activity is linked to experimental evidence."
  },
  "important_caveats": [
    "The source record is sequence-matched, but the author's exact database snapshot is unknown.",
    "The experimental functional evidence supports antibacterial activity; the cited GO annotation uses an inferred-evidence code."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [
      "A",
      "B"
    ],
    "reason": "A is the specific process supported by the record. Because the peptide disrupts bacterial membranes, B’s broader description of changing a process in another organism could also apply; the question does not clarify whether it seeks the most specific applicable GO term."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "GO_biological_process_0145",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The exact sequence matches the archived UniProt record for an antimicrobial peptide. That record reports experimental evidence of activity against multiple bacteria, including membrane disruption, supporting a role in defense response to bacterium. The GO annotation itself is keyword-inferred, while the functional activity is linked to experimental evidence.",
    "evidence_ids": ["H3", "H4", "C5"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence has a hydrophobic N-terminal region and a basic, likely secreted peptide region, which may suggest an antimicrobial peptide, but those features do not establish its specific biological process.",
    "missing_item_specific_fact": "The peptide’s experimentally observed antibacterial activity and its identity as marcin-18 are not supplied in the question.",
    "reason": "Selecting the specific process requires knowing this peptide’s functional activity. General sequence features alone do not reliably distinguish defense against bacteria from the broader effect on another organism represented by option B."
  },
  "question_ambiguity": {
    "multiple_defensible_options": ["A", "B"],
    "reason": "A is the specific process supported by the record. Because the peptide disrupts bacterial membranes, B’s broader description of changing a process in another organism could also apply; the question does not clarify whether it seeks the most specific applicable GO term."
  },
  "important_caveats": [
    "The source record is sequence-matched, but the author's exact database snapshot is unknown.",
    "The experimental functional evidence supports antibacterial activity; the cited GO annotation uses an inferred-evidence code."
  ]
}
```

</details>

## Before: Qwen3.8-Flash-Next-NVFP4

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> UniProt F6K5S6 (sequence matched) identifies the protein as 'Antimicrobial peptide marcin-18' from Olivierus martensii. The FUNCTION comment (ECO:0000269, experimental evidence from PubMed:29896190) describes potent activity against multiple Gram-positive and Gram-negative bacteria via bacterial membrane disruption, with in vivo efficacy in a mouse peritonitis model. The GO annotation GO:0042742 (defense response to bacterium) is assigned with IEA:UniProtKB-KW evidence code, but the underlying functional characterization is experimentally supported. The GO term definition ('Reactions triggered in response to the presence of a bacterium that act to protect the cell or organism') directly matches the described antimicrobial function.

Citations as saved: [C1](#evidence-c1), [C4](#evidence-c4), [C5](#evidence-c5), [H3](#evidence-h3), [H4](#evidence-h4), [GO3](#evidence-go3).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The 78-residue precursor sequence is markedly cationic (numerous Lys and Arg residues, especially in the C-terminal region) and amphipathic (alternating hydrophobic stretches with charged clusters). These are well-established hallmarks of antimicrobial peptides that act by disrupting bacterial membranes. Among the four options, this signature strongly excludes C (synaptonemal complex disassembly) and D (endocytosis), which are unrelated to small cationic peptides. Between A and B, the cationic amphipathic membrane-disrupting mechanism is the canonical mode of antimicrobial peptides, which are specifically annotated under 'defense response to bacterium' (GO:0042742) rather than the broader 'modulation of process of another organism' (GO:0035821). The GO definition of A ('Reactions triggered in response to the presence of a bacterium that act to protect the cell or organism') precisely describes the expected function of a cationic antimicrobial peptide.


**Missing item-specific fact**

> None critical. The cationic/amphipathic sequence signature and general knowledge of antimicrobial peptide biology provide sufficient grounds. Knowing the scorpion-venom origin would confirm but is not strictly required.


**Reason**

> A model with general knowledge of antimicrobial peptide structural signatures (cationic, amphipathic, short) can reason from the sequence to a bactericidal/defense function and select A over the clearly irrelevant C and D. The A-vs-B distinction relies on understanding that antimicrobial peptides are specifically classified under defense response to bacterium rather than the broader interspecies modulation term, which is standard GO annotation practice and general biological knowledge.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[
  "A",
  "B"
]
```

> Option B ('modulation of process of another organism') is a broader GO term that could technically encompass antimicrobial activity since the peptide affects a process in bacteria. However, GO:0042742 is the standard and more specific annotation for antimicrobial peptides, and the experimental evidence (membrane disruption, MIC values against bacteria, in vivo peritonitis model) aligns precisely with the definition of 'defense response to bacterium.' B is not strictly false but is less specific and not the primary annotation. This does not render the question defective since A is the clearly preferred answer.


### Important caveats

- The GO annotation GO:0042742 uses IEA (Inferred from Electronic Annotation) via UniProt keyword, not a direct GO evidence code. However, the underlying functional data (ECO:0000269, experimental) from PubMed:29896190 robustly supports the annotation.
- The sequence provided is the 78-residue precursor; the mature antimicrobial peptide is residues 31-41 (11 aa). The cationic signature is most concentrated in the C-terminal region corresponding to the mature peptide.
- The UniProt entry was first public in Feb 2025; the author's source snapshot is unknown. The historical entry (version 10, released Jan 2026) contains the same annotation.
- The accession F6K5S6 was inferred from dataset image-path metadata (reviewer-only); it was not provided to the evaluated model.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The 78-residue precursor sequence is markedly cationic (numerous Lys and Arg residues, especially in the C-terminal region) and amphipathic (alternating hydrophobic stretches with charged clusters). These are well-established hallmarks of antimicrobial peptides that act by disrupting bacterial membranes. Among the four options, this signature strongly excludes C (synaptonemal complex disassembly) and D (endocytosis), which are unrelated to small cationic peptides. Between A and B, the cationic amphipathic membrane-disrupting mechanism is the canonical mode of antimicrobial peptides, which are specifically annotated under 'defense response to bacterium' (GO:0042742) rather than the broader 'modulation of process of another organism' (GO:0035821). The GO definition of A ('Reactions triggered in response to the presence of a bacterium that act to protect the cell or organism') precisely describes the expected function of a cationic antimicrobial peptide.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "None critical. The cationic/amphipathic sequence signature and general knowledge of antimicrobial peptide biology provide sufficient grounds. Knowing the scorpion-venom origin would confirm but is not strictly required.",
    "reason": "A model with general knowledge of antimicrobial peptide structural signatures (cationic, amphipathic, short) can reason from the sequence to a bactericidal/defense function and select A over the clearly irrelevant C and D. The A-vs-B distinction relies on understanding that antimicrobial peptides are specifically classified under defense response to bacterium rather than the broader interspecies modulation term, which is standard GO annotation practice and general biological knowledge."
  },
  "case_id": "GO_biological_process_0145",
  "expected_answer_check": {
    "evidence_ids": [
      "C1",
      "C4",
      "C5",
      "H3",
      "H4",
      "GO3"
    ],
    "judgment": "supported",
    "reason": "UniProt F6K5S6 (sequence matched) identifies the protein as 'Antimicrobial peptide marcin-18' from Olivierus martensii. The FUNCTION comment (ECO:0000269, experimental evidence from PubMed:29896190) describes potent activity against multiple Gram-positive and Gram-negative bacteria via bacterial membrane disruption, with in vivo efficacy in a mouse peritonitis model. The GO annotation GO:0042742 (defense response to bacterium) is assigned with IEA:UniProtKB-KW evidence code, but the underlying functional characterization is experimentally supported. The GO term definition ('Reactions triggered in response to the presence of a bacterium that act to protect the cell or organism') directly matches the described antimicrobial function."
  },
  "important_caveats": [
    "The GO annotation GO:0042742 uses IEA (Inferred from Electronic Annotation) via UniProt keyword, not a direct GO evidence code. However, the underlying functional data (ECO:0000269, experimental) from PubMed:29896190 robustly supports the annotation.",
    "The sequence provided is the 78-residue precursor; the mature antimicrobial peptide is residues 31-41 (11 aa). The cationic signature is most concentrated in the C-terminal region corresponding to the mature peptide.",
    "The UniProt entry was first public in Feb 2025; the author's source snapshot is unknown. The historical entry (version 10, released Jan 2026) contains the same annotation.",
    "The accession F6K5S6 was inferred from dataset image-path metadata (reviewer-only); it was not provided to the evaluated model."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [
      "A",
      "B"
    ],
    "reason": "Option B ('modulation of process of another organism') is a broader GO term that could technically encompass antimicrobial activity since the peptide affects a process in bacteria. However, GO:0042742 is the standard and more specific annotation for antimicrobial peptides, and the experimental evidence (membrane disruption, MIC values against bacteria, in vivo peritonitis model) aligns precisely with the definition of 'defense response to bacterium.' B is not strictly false but is less specific and not the primary annotation. This does not render the question defective since A is the clearly preferred answer."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "GO_biological_process_0145",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "UniProt F6K5S6 (sequence matched) identifies the protein as 'Antimicrobial peptide marcin-18' from Olivierus martensii. The FUNCTION comment (ECO:0000269, experimental evidence from PubMed:29896190) describes potent activity against multiple Gram-positive and Gram-negative bacteria via bacterial membrane disruption, with in vivo efficacy in a mouse peritonitis model. The GO annotation GO:0042742 (defense response to bacterium) is assigned with IEA:UniProtKB-KW evidence code, but the underlying functional characterization is experimentally supported. The GO term definition ('Reactions triggered in response to the presence of a bacterium that act to protect the cell or organism') directly matches the described antimicrobial function.",
    "evidence_ids": ["C1", "C4", "C5", "H3", "H4", "GO3"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The 78-residue precursor sequence is markedly cationic (numerous Lys and Arg residues, especially in the C-terminal region) and amphipathic (alternating hydrophobic stretches with charged clusters). These are well-established hallmarks of antimicrobial peptides that act by disrupting bacterial membranes. Among the four options, this signature strongly excludes C (synaptonemal complex disassembly) and D (endocytosis), which are unrelated to small cationic peptides. Between A and B, the cationic amphipathic membrane-disrupting mechanism is the canonical mode of antimicrobial peptides, which are specifically annotated under 'defense response to bacterium' (GO:0042742) rather than the broader 'modulation of process of another organism' (GO:0035821). The GO definition of A ('Reactions triggered in response to the presence of a bacterium that act to protect the cell or organism') precisely describes the expected function of a cationic antimicrobial peptide.",
    "missing_item_specific_fact": "None critical. The cationic/amphipathic sequence signature and general knowledge of antimicrobial peptide biology provide sufficient grounds. Knowing the scorpion-venom origin would confirm but is not strictly required.",
    "reason": "A model with general knowledge of antimicrobial peptide structural signatures (cationic, amphipathic, short) can reason from the sequence to a bactericidal/defense function and select A over the clearly irrelevant C and D. The A-vs-B distinction relies on understanding that antimicrobial peptides are specifically classified under defense response to bacterium rather than the broader interspecies modulation term, which is standard GO annotation practice and general biological knowledge."
  },
  "question_ambiguity": {
    "multiple_defensible_options": ["A", "B"],
    "reason": "Option B ('modulation of process of another organism') is a broader GO term that could technically encompass antimicrobial activity since the peptide affects a process in bacteria. However, GO:0042742 is the standard and more specific annotation for antimicrobial peptides, and the experimental evidence (membrane disruption, MIC values against bacteria, in vivo peritonitis model) aligns precisely with the definition of 'defense response to bacterium.' B is not strictly false but is less specific and not the primary annotation. This does not render the question defective since A is the clearly preferred answer."
  },
  "important_caveats": [
    "The GO annotation GO:0042742 uses IEA (Inferred from Electronic Annotation) via UniProt keyword, not a direct GO evidence code. However, the underlying functional data (ECO:0000269, experimental) from PubMed:29896190 robustly supports the annotation.",
    "The sequence provided is the 78-residue precursor; the mature antimicrobial peptide is residues 31-41 (11 aa). The cationic signature is most concentrated in the C-terminal region corresponding to the mature peptide.",
    "The UniProt entry was first public in Feb 2025; the author's source snapshot is unknown. The historical entry (version 10, released Jan 2026) contains the same annotation.",
    "The accession F6K5S6 was inferred from dataset image-path metadata (reviewer-only); it was not provided to the evaluated model."
  ]
}
```

</details>

## After: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The sequence-matched record reports experimentally demonstrated antibacterial activity and bacterial-membrane disruption (H3; C5), supporting an antibacterial defense process. The historical record also assigns GO:0042742, though that annotation is IEA rather than direct experimental evidence for the GO term (H4).

Citations as saved: [H3](#evidence-h3), [C5](#evidence-c5), [H4](#evidence-h4).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The short sequence has a hydrophobic N-terminal region and a basic, hydrophobic peptide region, a pattern compatible with a secreted antimicrobial peptide. Transferable knowledge that such peptides often disrupt bacterial membranes makes defense response to bacterium (A) a credible best fit over endocytosis or synaptonemal-complex disassembly, and more specific than the broad interspecies-modulation option.


**Missing item-specific fact**

Empty string, as saved.


**Reason**

> A family-level antimicrobial-peptide inference is available from the sequence pattern and distinguishes A from the unrelated cellular-process distractors. It supports A probabilistically, but does not establish the peptide's natural role or uniquely exclude the broader B.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[
  "A",
  "B"
]
```

> An antimicrobial peptide that disrupts bacterial membranes can be described as antibacterial defense, but its direct effect also changes a process in another organism, fitting B's broad wording. A is the more specific and conventional choice for antibacterial activity.


### Important caveats

- The experimental evidence establishes antibacterial activity, not by itself the peptide's natural in-organism biological role.
- The reviewer-only record matches the supplied sequence, but the exact author source snapshot is unknown.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The short sequence has a hydrophobic N-terminal region and a basic, hydrophobic peptide region, a pattern compatible with a secreted antimicrobial peptide. Transferable knowledge that such peptides often disrupt bacterial membranes makes defense response to bacterium (A) a credible best fit over endocytosis or synaptonemal-complex disassembly, and more specific than the broad interspecies-modulation option.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "",
    "reason": "A family-level antimicrobial-peptide inference is available from the sequence pattern and distinguishes A from the unrelated cellular-process distractors. It supports A probabilistically, but does not establish the peptide's natural role or uniquely exclude the broader B."
  },
  "case_id": "GO_biological_process_0145",
  "expected_answer_check": {
    "evidence_ids": [
      "H3",
      "C5",
      "H4"
    ],
    "judgment": "supported",
    "reason": "The sequence-matched record reports experimentally demonstrated antibacterial activity and bacterial-membrane disruption (H3; C5), supporting an antibacterial defense process. The historical record also assigns GO:0042742, though that annotation is IEA rather than direct experimental evidence for the GO term (H4)."
  },
  "important_caveats": [
    "The experimental evidence establishes antibacterial activity, not by itself the peptide's natural in-organism biological role.",
    "The reviewer-only record matches the supplied sequence, but the exact author source snapshot is unknown."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [
      "A",
      "B"
    ],
    "reason": "An antimicrobial peptide that disrupts bacterial membranes can be described as antibacterial defense, but its direct effect also changes a process in another organism, fitting B's broad wording. A is the more specific and conventional choice for antibacterial activity."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "GO_biological_process_0145",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The sequence-matched record reports experimentally demonstrated antibacterial activity and bacterial-membrane disruption (H3; C5), supporting an antibacterial defense process. The historical record also assigns GO:0042742, though that annotation is IEA rather than direct experimental evidence for the GO term (H4).",
    "evidence_ids": ["H3", "C5", "H4"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The short sequence has a hydrophobic N-terminal region and a basic, hydrophobic peptide region, a pattern compatible with a secreted antimicrobial peptide. Transferable knowledge that such peptides often disrupt bacterial membranes makes defense response to bacterium (A) a credible best fit over endocytosis or synaptonemal-complex disassembly, and more specific than the broad interspecies-modulation option.",
    "missing_item_specific_fact": "",
    "reason": "A family-level antimicrobial-peptide inference is available from the sequence pattern and distinguishes A from the unrelated cellular-process distractors. It supports A probabilistically, but does not establish the peptide's natural role or uniquely exclude the broader B."
  },
  "question_ambiguity": {
    "multiple_defensible_options": ["A", "B"],
    "reason": "An antimicrobial peptide that disrupts bacterial membranes can be described as antibacterial defense, but its direct effect also changes a process in another organism, fitting B's broad wording. A is the more specific and conventional choice for antibacterial activity."
  },
  "important_caveats": [
    "The experimental evidence establishes antibacterial activity, not by itself the peptide's natural in-organism biological role.",
    "The reviewer-only record matches the supplied sequence, but the exact author source snapshot is unknown."
  ]
}
```

</details>

## After: Qwen3.8-Flash-Next-NVFP4

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The reviewer evidence confirms the protein is antimicrobial peptide marcin-18 from scorpion venom (Olivierus martensii). UniProt entry F6K5S6 carries GO:0042742 (defense response to bacterium) annotation. The underlying experimental evidence (ECO:0000269, PubMed 29896190) demonstrates potent bactericidal activity via bacterial membrane disruption against multiple Gram-positive and Gram-negative species. The GO annotation code is IEA (from keyword), but the keyword assignment is backed by experimental MIC data and in vivo efficacy. The expected answer A is well-supported.

Citations as saved: [C4](#evidence-c4), [C5](#evidence-c5), [H3](#evidence-h3), [H4](#evidence-h4).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The 78-residue sequence exhibits a canonical antimicrobial peptide (AMP) architecture: a hydrophobic N-terminal signal peptide region (MQFKKQLMVIFLAYFLVV) followed by a highly cationic, amphipathic mature peptide (RKNQRSRSIMKRDLENLFDPYQRNLELDRLLKQLPNY) rich in Arg/Lys and hydrophobic residues. This small, cationic, amphipathic design with a cleavable signal peptide is a well-established signature of AMPs across arthropod venoms and other innate immune systems. A model recognizing this AMP motif can map the primary biological process to 'defense response to bacterium' (A), since AMPs function by disrupting bacterial membranes as part of innate antibacterial defense. Option C (synaptonemal complex disassembly) involves meiotic chromosome pairing structures and has no sequence or mechanistic connection to a small cationic peptide. Option D (endocytosis) involves vesicle formation and membrane trafficking machinery, unrelated to this sequence. Option B (modulation of process of another organism) is a broader interspecies-interaction term; while an AMP technically affects another organism, the PRIMARY and most specific biological process for a bactericidal peptide is defense response to bacterium, which sits under the defense-response branch of GO rather than the interspecies-interaction branch.


**Missing item-specific fact**

Empty string, as saved.


**Reason**

> The sequence features (small size, signal peptide, cationic amphipathic mature domain) are transferable AMP hallmarks recognizable from knowledge of many AMP families (defensins, magainins, LL-37, scorpion defensins, etc.). This family-level pattern meaningfully distinguishes A from C and D, and the specificity of 'defense response to bacterium' over the broader 'modulation of process of another organism' follows from the direct bactericidal mechanism implied by the cationic amphipathic architecture. No target-specific database lookup is required.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> Option A is clearly the most specific and accurate primary biological process for a bactericidal AMP. Option B is a broader GO term under a different branch (interspecies interaction) and does not capture the defensive/antibacterial specificity. Options C and D are mechanistically unrelated. No genuine ambiguity exists among the offered choices.


### Important caveats

- The GO annotation in UniProt is IEA (Inferred from Electronic Annotation via keyword), but the keyword is supported by experimental MIC and in vivo data (ECO:0000269).
- The reviewer identified the protein as F6K5S6 via image-path metadata not available to the evaluated model; however, the sequence features alone are sufficient for the reasoning argument.
- The mature peptide is residues 31-41 per UniProt, meaning the full 78-aa precursor includes a signal peptide and propeptide region; the cationic amphipathic signature is most prominent in the C-terminal portion.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The 78-residue sequence exhibits a canonical antimicrobial peptide (AMP) architecture: a hydrophobic N-terminal signal peptide region (MQFKKQLMVIFLAYFLVV) followed by a highly cationic, amphipathic mature peptide (RKNQRSRSIMKRDLENLFDPYQRNLELDRLLKQLPNY) rich in Arg/Lys and hydrophobic residues. This small, cationic, amphipathic design with a cleavable signal peptide is a well-established signature of AMPs across arthropod venoms and other innate immune systems. A model recognizing this AMP motif can map the primary biological process to 'defense response to bacterium' (A), since AMPs function by disrupting bacterial membranes as part of innate antibacterial defense. Option C (synaptonemal complex disassembly) involves meiotic chromosome pairing structures and has no sequence or mechanistic connection to a small cationic peptide. Option D (endocytosis) involves vesicle formation and membrane trafficking machinery, unrelated to this sequence. Option B (modulation of process of another organism) is a broader interspecies-interaction term; while an AMP technically affects another organism, the PRIMARY and most specific biological process for a bactericidal peptide is defense response to bacterium, which sits under the defense-response branch of GO rather than the interspecies-interaction branch.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "",
    "reason": "The sequence features (small size, signal peptide, cationic amphipathic mature domain) are transferable AMP hallmarks recognizable from knowledge of many AMP families (defensins, magainins, LL-37, scorpion defensins, etc.). This family-level pattern meaningfully distinguishes A from C and D, and the specificity of 'defense response to bacterium' over the broader 'modulation of process of another organism' follows from the direct bactericidal mechanism implied by the cationic amphipathic architecture. No target-specific database lookup is required."
  },
  "case_id": "GO_biological_process_0145",
  "expected_answer_check": {
    "evidence_ids": [
      "C4",
      "C5",
      "H3",
      "H4"
    ],
    "judgment": "supported",
    "reason": "The reviewer evidence confirms the protein is antimicrobial peptide marcin-18 from scorpion venom (Olivierus martensii). UniProt entry F6K5S6 carries GO:0042742 (defense response to bacterium) annotation. The underlying experimental evidence (ECO:0000269, PubMed 29896190) demonstrates potent bactericidal activity via bacterial membrane disruption against multiple Gram-positive and Gram-negative species. The GO annotation code is IEA (from keyword), but the keyword assignment is backed by experimental MIC data and in vivo efficacy. The expected answer A is well-supported."
  },
  "important_caveats": [
    "The GO annotation in UniProt is IEA (Inferred from Electronic Annotation via keyword), but the keyword is supported by experimental MIC and in vivo data (ECO:0000269).",
    "The reviewer identified the protein as F6K5S6 via image-path metadata not available to the evaluated model; however, the sequence features alone are sufficient for the reasoning argument.",
    "The mature peptide is residues 31-41 per UniProt, meaning the full 78-aa precursor includes a signal peptide and propeptide region; the cationic amphipathic signature is most prominent in the C-terminal portion."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Option A is clearly the most specific and accurate primary biological process for a bactericidal AMP. Option B is a broader GO term under a different branch (interspecies interaction) and does not capture the defensive/antibacterial specificity. Options C and D are mechanistically unrelated. No genuine ambiguity exists among the offered choices."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "GO_biological_process_0145",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The reviewer evidence confirms the protein is antimicrobial peptide marcin-18 from scorpion venom (Olivierus martensii). UniProt entry F6K5S6 carries GO:0042742 (defense response to bacterium) annotation. The underlying experimental evidence (ECO:0000269, PubMed 29896190) demonstrates potent bactericidal activity via bacterial membrane disruption against multiple Gram-positive and Gram-negative species. The GO annotation code is IEA (from keyword), but the keyword assignment is backed by experimental MIC data and in vivo efficacy. The expected answer A is well-supported.",
    "evidence_ids": ["C4", "C5", "H3", "H4"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The 78-residue sequence exhibits a canonical antimicrobial peptide (AMP) architecture: a hydrophobic N-terminal signal peptide region (MQFKKQLMVIFLAYFLVV) followed by a highly cationic, amphipathic mature peptide (RKNQRSRSIMKRDLENLFDPYQRNLELDRLLKQLPNY) rich in Arg/Lys and hydrophobic residues. This small, cationic, amphipathic design with a cleavable signal peptide is a well-established signature of AMPs across arthropod venoms and other innate immune systems. A model recognizing this AMP motif can map the primary biological process to 'defense response to bacterium' (A), since AMPs function by disrupting bacterial membranes as part of innate antibacterial defense. Option C (synaptonemal complex disassembly) involves meiotic chromosome pairing structures and has no sequence or mechanistic connection to a small cationic peptide. Option D (endocytosis) involves vesicle formation and membrane trafficking machinery, unrelated to this sequence. Option B (modulation of process of another organism) is a broader interspecies-interaction term; while an AMP technically affects another organism, the PRIMARY and most specific biological process for a bactericidal peptide is defense response to bacterium, which sits under the defense-response branch of GO rather than the interspecies-interaction branch.",
    "missing_item_specific_fact": "",
    "reason": "The sequence features (small size, signal peptide, cationic amphipathic mature domain) are transferable AMP hallmarks recognizable from knowledge of many AMP families (defensins, magainins, LL-37, scorpion defensins, etc.). This family-level pattern meaningfully distinguishes A from C and D, and the specificity of 'defense response to bacterium' over the broader 'modulation of process of another organism' follows from the direct bactericidal mechanism implied by the cationic amphipathic architecture. No target-specific database lookup is required."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Option A is clearly the most specific and accurate primary biological process for a bactericidal AMP. Option B is a broader GO term under a different branch (interspecies interaction) and does not capture the defensive/antibacterial specificity. Options C and D are mechanistically unrelated. No genuine ambiguity exists among the offered choices."
  },
  "important_caveats": [
    "The GO annotation in UniProt is IEA (Inferred from Electronic Annotation via keyword), but the keyword is supported by experimental MIC and in vivo data (ECO:0000269).",
    "The reviewer identified the protein as F6K5S6 via image-path metadata not available to the evaluated model; however, the sequence features alone are sufficient for the reasoning argument.",
    "The mature peptide is residues 31-41 per UniProt, meaning the full 78-aa precursor includes a signal peptide and propeptide region; the cationic amphipathic signature is most prominent in the C-terminal portion."
  ]
}
```

</details>

## Existing project source checks of the old Luna review only

These unchanged notes concern the earlier Luna claims. They do not validate either new review or the old Qwen review. No new scientific adjudication was performed.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Complete reviewer-only evidence and qualifications

All excerpts supplied in the original and revised reviewer user message follow. This material was not available to the original evaluated model. Accession identity came from dataset image-path metadata. Source support and transferable discrimination are separate judgments.

**Applicability metadata, unchanged:**

```json
{
  "requested_accession": "F6K5S6",
  "identity_origin": "reviewer-only accession inferred mechanically from original dataset image-path metadata; this accession/metadata was absent from evaluated model input",
  "benchmark_sequence_sha256": "37fb44735b338fa00069dbbd740d7965984da769d2f7e9bedaf0353062bcdca6",
  "benchmark_sequence_length": 78,
  "current_status": "retrieved",
  "current_sequence_comparison": "matched",
  "current_entry_audit": {
    "entryVersion": 11,
    "firstPublicDate": "2025-02-05",
    "lastAnnotationUpdateDate": "2026-09-02",
    "lastSequenceUpdateDate": "2011-07-27",
    "sequenceVersion": 1
  },
  "current_uniprot_release": "2026_03",
  "current_record_sha256": "0e2af06e53ab0532a27874d9c775be538bb77c2a55cb7cf37588f4d37ddb6dd0",
  "current_source_sequence_sha256": "37fb44735b338fa00069dbbd740d7965984da769d2f7e9bedaf0353062bcdca6",
  "current_source_sequence_length": 78,
  "historical_status": "retrieved",
  "historical_cutoff_date": "2026-05-07",
  "historical_sequence_comparison": "matched",
  "selected_historical_entry_version": 10,
  "selected_historical_version": {
    "accession": "F6K5S6",
    "database": "Swiss-Prot",
    "entryVersion": 10,
    "firstRelease": "2026_01/2026_01",
    "firstReleaseDate": "28-Jan-2026",
    "lastRelease": "2026_02/2026_02",
    "lastReleaseDate": "10-Jun-2026",
    "name": "NDBM_OLIMR",
    "sequenceVersion": 1
  },
  "selected_historical_record_sha256": "d3e33b1213622427b6ee88bca39ec4fa6cf32de4466e1147747325f78a3ee193",
  "selected_historical_source_sequence_sha256": "37fb44735b338fa00069dbbd740d7965984da769d2f7e9bedaf0353062bcdca6",
  "selected_historical_source_sequence_length": 78,
  "latest_at_cutoff_sequence_comparison": "matched",
  "historical_sequence_versions_checked": [
    {
      "entry_version": 10,
      "exact_sequence_comparison": "matched",
      "sequence_version": 1
    }
  ],
  "actual_author_source_snapshot": "unknown",
  "numbering": "Canonical entry coordinates; construct or isoform numbering is not assumed."
}
```

**Qualifications, unchanged:**

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.
- Ontology names and EXACT synonyms match options mechanically; no answer-support judgment is made.
- Only is_a and part_of edges are used in supplied graph paths; all qualifiers and obsolete/replaced_by tags remain in literal source blocks.
- The ontology is newer than the benchmark repository commit; the exact author ontology snapshot is unknown.
- No matching term or path does not establish that an option is false.

### Evidence C1

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/F6K5S6.json)

```json
{
  "evidence_id": "C1",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/F6K5S6.json",
  "source_sha256": "0e2af06e53ab0532a27874d9c775be538bb77c2a55cb7cf37588f4d37ddb6dd0",
  "retrieved_utc": "2026-11-02T04:28:15.245104+00:00",
  "json_pointer": "/primaryAccession",
  "excerpt": "\"F6K5S6\"",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C2

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/F6K5S6.json)

```json
{
  "evidence_id": "C2",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/F6K5S6.json",
  "source_sha256": "0e2af06e53ab0532a27874d9c775be538bb77c2a55cb7cf37588f4d37ddb6dd0",
  "retrieved_utc": "2026-11-02T04:28:15.245104+00:00",
  "json_pointer": "/entryAudit",
  "excerpt": "{\"entryVersion\":11,\"firstPublicDate\":\"2025-02-05\",\"lastAnnotationUpdateDate\":\"2026-09-02\",\"lastSequenceUpdateDate\":\"2011-07-27\",\"sequenceVersion\":1}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C3

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/F6K5S6.json)

```json
{
  "evidence_id": "C3",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/F6K5S6.json",
  "source_sha256": "0e2af06e53ab0532a27874d9c775be538bb77c2a55cb7cf37588f4d37ddb6dd0",
  "retrieved_utc": "2026-11-02T04:28:15.245104+00:00",
  "json_pointer": "/organism",
  "excerpt": "{\"commonName\":\"Manchurian scorpion\",\"lineage\":[\"Eukaryota\",\"Metazoa\",\"Ecdysozoa\",\"Arthropoda\",\"Chelicerata\",\"Arachnida\",\"Scorpiones\",\"Buthida\",\"Buthoidea\",\"Buthidae\",\"Olivierus\"],\"scientificName\":\"Olivierus martensii\",\"synonyms\":[\"Mesobuthus martensii\"],\"taxonId\":34649}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/F6K5S6.json)

```json
{
  "evidence_id": "C4",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/F6K5S6.json",
  "source_sha256": "0e2af06e53ab0532a27874d9c775be538bb77c2a55cb7cf37588f4d37ddb6dd0",
  "retrieved_utc": "2026-11-02T04:28:15.245104+00:00",
  "json_pointer": "/proteinDescription",
  "excerpt": "{\"flag\":\"Precursor\",\"recommendedName\":{\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000303\",\"id\":\"29896190\",\"source\":\"PubMed\"}],\"value\":\"Antimicrobial peptide marcin-18\"}}}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/F6K5S6.json)

```json
{
  "evidence_id": "C5",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/F6K5S6.json",
  "source_sha256": "0e2af06e53ab0532a27874d9c775be538bb77c2a55cb7cf37588f4d37ddb6dd0",
  "retrieved_utc": "2026-11-02T04:28:15.245104+00:00",
  "json_pointer": "/comments/0",
  "excerpt": "{\"commentType\":\"FUNCTION\",\"texts\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000269\",\"id\":\"29896190\",\"source\":\"PubMed\"}],\"value\":\"Antimicrobial peptide with potent activity against bacteria. Acts by fastly disrupting the bacterial membrane. Shows activity against Gram-positive bacteria S.aureus (MIC=1.5-2.9 uM) and S.epidermidis (MIC=2.9 uM), M.luteus (MIC=23.4 uM), B.thuringiensis (MIC=2.9 uM), B.subtilis (MIC=2.9 uM) and Gram-negative bacteria E.coli (MIC=5.9-11.7 uM) and P.aeruginosa (MIC=5.9 uM), as well as against penicillin (MIC=2.9 uM) and methicillin (MIC=1.5-2.9 uM) resistant bacteria. Antibiotic activity is not affected by major negatively charged components of the prokaryotic cell wall (e.g. lipopolysaccharides and lipoteichoic acid). In vivo, in a mouse model of lethal peritonitis, shows potent antibiotic activity without cytotoxicity, improving the survival rate\"}]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C6

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/F6K5S6.json)

```json
{
  "evidence_id": "C6",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/F6K5S6.json",
  "source_sha256": "0e2af06e53ab0532a27874d9c775be538bb77c2a55cb7cf37588f4d37ddb6dd0",
  "retrieved_utc": "2026-11-02T04:28:15.245104+00:00",
  "json_pointer": "/references/2",
  "excerpt": "{\"citation\":{\"authors\":[\"Liu G.\",\"Yang F.\",\"Li F.\",\"Li Z.\",\"Lang Y.\",\"Shen B.\",\"Wu Y.\",\"Li W.\",\"Harrison P.L.\",\"Strong P.N.\",\"Xie Y.\",\"Miller K.\",\"Cao Z.\"],\"citationCrossReferences\":[{\"database\":\"PubMed\",\"id\":\"29896190\"},{\"database\":\"DOI\",\"id\":\"10.3389/fmicb.2018.01159\"}],\"citationType\":\"journal article\",\"firstPage\":\"1159\",\"id\":\"29896190\",\"journal\":\"Front. Microbiol.\",\"lastPage\":\"1159\",\"publicationDate\":\"2018\",\"title\":\"Therapeutic potential of a scorpion venom-derived antimicrobial peptide and its homologs against antibiotic-resistant Gram-positive bacteria.\",\"volume\":\"9\"},\"evidences\":[{\"evidenceCode\":\"ECO:0000312\",\"id\":\"ADT89762.1\",\"source\":\"EMBL\"}],\"referenceComments\":[{\"type\":\"TISSUE\",\"value\":\"Venom\"}],\"referenceNumber\":3,\"referencePositions\":[\"NUCLEOTIDE SEQUENCE [GENOMIC DNA]\",\"PROTEIN SEQUENCE OF 31-41\",\"FUNCTION\",\"BIOASSAY\",\"SYNTHESIS OF 24-41\",\"IDENTIFICATION BY MASS SPECTROMETRY\",\"SUBCELLULAR LOCATION\",\"PROBABLE AMIDATION AT ARG-41\",\"BIOPHYSICOCHEMICAL PROPERTIES\",\"CIRCULAR DICHROISM ANALYSIS\"]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence H1

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/F6K5S6?format=txt&versions=10)

```json
{
  "evidence_id": "H1",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/F6K5S6?format=txt&versions=10",
  "source_sha256": "d3e33b1213622427b6ee88bca39ec4fa6cf32de4466e1147747325f78a3ee193",
  "retrieved_utc": "2026-11-02T04:28:18.617653+00:00",
  "source_locator": "lines 1-11",
  "excerpt": "ID   NDBM_OLIMR              Reviewed;          78 AA.\nAC   F6K5S6;\nDT   05-FEB-2025, integrated into UniProtKB/Swiss-Prot.\nDT   27-JUL-2011, sequence version 1.\nDT   28-JAN-2026, entry version 10.\nDE   RecName: Full=Antimicrobial peptide marcin-18 {ECO:0000303|PubMed:29896190};\nDE   Flags: Precursor;\nOS   Olivierus martensii (Manchurian scorpion) (Mesobuthus martensii).\nOC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;\nOC   Scorpiones; Buthida; Buthoidea; Buthidae; Olivierus.\nOX   NCBI_TaxID=34649;\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 10,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H2

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/F6K5S6?format=txt&versions=10)

```json
{
  "evidence_id": "H2",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/F6K5S6?format=txt&versions=10",
  "source_sha256": "d3e33b1213622427b6ee88bca39ec4fa6cf32de4466e1147747325f78a3ee193",
  "retrieved_utc": "2026-11-02T04:28:18.617653+00:00",
  "source_locator": "lines 30-41",
  "excerpt": "RN   [3] {ECO:0000312|EMBL:ADT89762.1}\nRP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], PROTEIN SEQUENCE OF 31-41, FUNCTION,\nRP   BIOASSAY, SYNTHESIS OF 24-41, IDENTIFICATION BY MASS SPECTROMETRY,\nRP   SUBCELLULAR LOCATION, PROBABLE AMIDATION AT ARG-41, BIOPHYSICOCHEMICAL\nRP   PROPERTIES, AND CIRCULAR DICHROISM ANALYSIS.\nRC   TISSUE=Venom;\nRX   PubMed=29896190; DOI=10.3389/fmicb.2018.01159;\nRA   Liu G., Yang F., Li F., Li Z., Lang Y., Shen B., Wu Y., Li W.,\nRA   Harrison P.L., Strong P.N., Xie Y., Miller K., Cao Z.;\nRT   \"Therapeutic potential of a scorpion venom-derived antimicrobial peptide\nRT   and its homologs against antibiotic-resistant Gram-positive bacteria.\";\nRL   Front. Microbiol. 9:1159-1159(2018).\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 10,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/F6K5S6?format=txt&versions=10)

```json
{
  "evidence_id": "H3",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/F6K5S6?format=txt&versions=10",
  "source_sha256": "d3e33b1213622427b6ee88bca39ec4fa6cf32de4466e1147747325f78a3ee193",
  "retrieved_utc": "2026-11-02T04:28:18.617653+00:00",
  "source_locator": "lines 42-54",
  "excerpt": "CC   -!- FUNCTION: Antimicrobial peptide with potent activity against bacteria.\nCC       Acts by fastly disrupting the bacterial membrane. Shows activity\nCC       against Gram-positive bacteria S.aureus (MIC=1.5-2.9 uM) and\nCC       S.epidermidis (MIC=2.9 uM), M.luteus (MIC=23.4 uM), B.thuringiensis\nCC       (MIC=2.9 uM), B.subtilis (MIC=2.9 uM) and Gram-negative bacteria E.coli\nCC       (MIC=5.9-11.7 uM) and P.aeruginosa (MIC=5.9 uM), as well as against\nCC       penicillin (MIC=2.9 uM) and methicillin (MIC=1.5-2.9 uM) resistant\nCC       bacteria. Antibiotic activity is not affected by major negatively\nCC       charged components of the prokaryotic cell wall (e.g.\nCC       lipopolysaccharides and lipoteichoic acid). In vivo, in a mouse model\nCC       of lethal peritonitis, shows potent antibiotic activity without\nCC       cytotoxicity, improving the survival rate.\nCC       {ECO:0000269|PubMed:29896190}.\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 10,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H4

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/F6K5S6?format=txt&versions=10)

```json
{
  "evidence_id": "H4",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/F6K5S6?format=txt&versions=10",
  "source_sha256": "d3e33b1213622427b6ee88bca39ec4fa6cf32de4466e1147747325f78a3ee193",
  "retrieved_utc": "2026-11-02T04:28:18.617653+00:00",
  "source_locator": "lines 77-77",
  "excerpt": "DR   GO; GO:0042742; P:defense response to bacterium; IEA:UniProtKB-KW.\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 10,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence GO1

[Gene Ontology current ontology](https://current.geneontology.org/ontology/go-basic.obo)

```json
{
  "evidence_id": "GO1",
  "source": "Gene Ontology current ontology",
  "url": "https://current.geneontology.org/ontology/go-basic.obo",
  "source_sha256": "b08d45b268b8c24ccb2513dbbbc7d4df9f6521c099b413f79eb31e06e0fa3bcc",
  "retrieved_utc": "2026-11-01T07:04:24.975173+00:00",
  "source_locator": "lines 71379-71394",
  "excerpt": "[Term]\nid: GO:0006897\nname: endocytosis\nnamespace: biological_process\nalt_id: GO:0016193\nalt_id: GO:0016196\nalt_id: GO:0098701\ndef: \"A cellular process in which cells take up external materials or membrane constituents by the invagination of a part of the plasma membrane to form a new membrane-bounded vesicle.\" [GOC:mah, ISBN:0198506732, ISBN:0716731363, Wikipedia:Endocytosis]\nsubset: goslim_yeast\nsynonym: \"endocytic import into cell\" EXACT []\nsynonym: \"nonselective vesicle endocytosis\" RELATED []\nsynonym: \"plasma membrane invagination\" NARROW []\nsynonym: \"vesicle endocytosis\" EXACT []\nxref: Wikipedia:Endocytosis\nis_a: GO:0098657 ! import into cell\n\n",
  "excerpt_format": "literal contiguous OBO lines",
  "source_scope": "current ontology; exact historical benchmark ontology unknown",
  "go_id": "GO:0006897"
}
```

### Evidence GO2

[Gene Ontology current ontology](https://current.geneontology.org/ontology/go-basic.obo)

```json
{
  "evidence_id": "GO2",
  "source": "Gene Ontology current ontology",
  "url": "https://current.geneontology.org/ontology/go-basic.obo",
  "source_sha256": "b08d45b268b8c24ccb2513dbbbc7d4df9f6521c099b413f79eb31e06e0fa3bcc",
  "retrieved_utc": "2026-11-01T07:04:24.975173+00:00",
  "source_locator": "lines 221582-221594",
  "excerpt": "[Term]\nid: GO:0035821\nname: modulation of process of another organism\nnamespace: biological_process\ndef: \"A process in which an organism effects a change in a biological process in another organism.\" [GOC:bf]\nsynonym: \"modification of morphology or physiology of other organism\" EXACT []\nsynonym: \"modulation of process of other organism\" EXACT []\nsynonym: \"regulation of morphology of other organism\" NARROW [GOC:bf]\nsynonym: \"regulation of morphology or physiology of other organism\" RELATED [GOC:bf]\nsynonym: \"regulation of physiological process of other organism\" NARROW [GOC:bf]\nsynonym: \"regulation of physiology of other organism\" NARROW [GOC:bf]\nis_a: GO:0044419 ! biological process involved in interspecies interaction between organisms\n\n",
  "excerpt_format": "literal contiguous OBO lines",
  "source_scope": "current ontology; exact historical benchmark ontology unknown",
  "go_id": "GO:0035821"
}
```

### Evidence GO3

[Gene Ontology current ontology](https://current.geneontology.org/ontology/go-basic.obo)

```json
{
  "evidence_id": "GO3",
  "source": "Gene Ontology current ontology",
  "url": "https://current.geneontology.org/ontology/go-basic.obo",
  "source_sha256": "b08d45b268b8c24ccb2513dbbbc7d4df9f6521c099b413f79eb31e06e0fa3bcc",
  "retrieved_utc": "2026-11-01T07:04:24.975173+00:00",
  "source_locator": "lines 240383-240399",
  "excerpt": "[Term]\nid: GO:0042742\nname: defense response to bacterium\nnamespace: biological_process\nalt_id: GO:0009816\nalt_id: GO:0042830\ndef: \"Reactions triggered in response to the presence of a bacterium that act to protect the cell or organism.\" [GOC:jl]\nsynonym: \"antibacterial peptide activity\" RELATED []\nsynonym: \"defence response to bacteria\" EXACT []\nsynonym: \"defence response to bacterium\" EXACT []\nsynonym: \"defense response to bacteria\" EXACT []\nsynonym: \"defense response to bacterium, incompatible interaction\" NARROW []\nsynonym: \"resistance response to pathogenic bacteria\" NARROW []\nsynonym: \"resistance response to pathogenic bacterium\" NARROW []\nis_a: GO:0006952 ! defense response\nis_a: GO:0009617 ! response to bacterium\n\n",
  "excerpt_format": "literal contiguous OBO lines",
  "source_scope": "current ontology; exact historical benchmark ontology unknown",
  "go_id": "GO:0042742"
}
```

### Evidence GO4

[Gene Ontology current ontology](https://current.geneontology.org/ontology/go-basic.obo)

```json
{
  "evidence_id": "GO4",
  "source": "Gene Ontology current ontology",
  "url": "https://current.geneontology.org/ontology/go-basic.obo",
  "source_sha256": "b08d45b268b8c24ccb2513dbbbc7d4df9f6521c099b413f79eb31e06e0fa3bcc",
  "retrieved_utc": "2026-11-01T07:04:24.975173+00:00",
  "source_locator": "lines 365078-365085",
  "excerpt": "[Term]\nid: GO:0070194\nname: synaptonemal complex disassembly\nnamespace: biological_process\ndef: \"The controlled breakdown of a synaptonemal complex.\" [GOC:mah]\nis_a: GO:0022411 ! cellular component disassembly\nis_a: GO:0070193 ! synaptonemal complex organization\n\n",
  "excerpt_format": "literal contiguous OBO lines",
  "source_scope": "current ontology; exact historical benchmark ontology unknown",
  "go_id": "GO:0070194"
}
```

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/GO_biological_process.json), zero-based source row 145. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). [Source credits](../THIRD_PARTY_NOTICES.md).
